U.S. flag

An official website of the United States government

NM_033360.4(KRAS):c.68T>G (p.Leu23Arg) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 15, 2014
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000157948.1

Allele description [Variation Report for NM_033360.4(KRAS):c.68T>G (p.Leu23Arg)]

NM_033360.4(KRAS):c.68T>G (p.Leu23Arg)

Gene:
KRAS:KRAS proto-oncogene, GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p12.1
Genomic location:
Preferred name:
NM_033360.4(KRAS):c.68T>G (p.Leu23Arg)
Other names:
p.L23R:CTA>CGA
HGVS:
  • NC_000012.12:g.25245317A>C
  • NG_007524.1:g.10604T>G
  • NG_007524.2:g.10687T>G
  • NM_001369786.1:c.68T>G
  • NM_001369787.1:c.68T>G
  • NM_004985.5:c.68T>GMANE SELECT
  • NM_033360.4:c.68T>G
  • NP_001356715.1:p.Leu23Arg
  • NP_001356716.1:p.Leu23Arg
  • NP_004976.2:p.Leu23Arg
  • NP_203524.1:p.Leu23Arg
  • LRG_344t1:c.68T>G
  • LRG_344t2:c.68T>G
  • LRG_344:g.10687T>G
  • LRG_344p1:p.Leu23Arg
  • LRG_344p2:p.Leu23Arg
  • NC_000012.11:g.25398251A>C
  • NM_004985.3:c.68T>G
Protein change:
L23R
Links:
dbSNP: rs730880472
NCBI 1000 Genomes Browser:
rs730880472
Molecular consequence:
  • NM_001369786.1:c.68T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001369787.1:c.68T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004985.5:c.68T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033360.4:c.68T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000207883GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(Jan 15, 2014)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000207883.9

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

p.Leu23Arg (CTA>CGA): c.68 T>G in exon 2 of the KRAS gene (NM_004985.3). The L23R missense change likely associated with a KRAS-related disorder was identified in the KRAS gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge.The L23R amino acid substitution is non-conservative with a neutral, non-polar residue (Leu) being replaced by a positively charged, polar residue (Arg). The residue at which this substitution occurs is highly conserved across species. Other missense mutations in nearby residues (Q22R, Q22E, N26I) havebeen reported in association with Noonan and cardio-facio-cutaneous syndromes. The L23R missense change was not reported inapproximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, L23R is a strong candidate for a disease-causing mutation, however, the possibility that it is a benign variant cannot be excluded. The variant is found in NOONAN panel(s).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022